$4.990
-0.211 (-4.22%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
IMRX Prediction & Forecast by Similar Chart Analysis
Alphio's IMRX stock price prediction model matches the current Immuneering Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.91 (-1.59%). The 1-week path is $5.10 (+2.18%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Immuneering Corp Stock?
Immuneering Corp is a good buy right now due to its current price of $4.99, which is significantly lower than the average analyst price target of $15.5. The company has a strong cash position of $182.7 million, ensuring operational capacity until 2029, which supports its ongoing clinical trials. Additionally, insider buying has increased by 266.10% over the last month, indicating strong confidence from those closest to the company. However, the main risk is the negative earnings per share (EPS) of -0.27 reported in Q2 2026, reflecting ongoing losses that could impact future performance.
IMRX stock price ended at $4.99 on Friday, after losing -4.22%
Immuneering Corp (IMRX) last closed at $4.99, losing -4.22%. These facts feed the 1-day and 1-week IMRX price prediction above.
Forecast Drivers
Immuneering Corp (IMRX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches IMRX, ranked by similarity.
Seasonality analysis for IMRX
Historically the probability of a positive August return for IMRX is 33.33%. September offers the highest probability of a positive month at 51.22%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for IMRX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $3.12 | $3.69 | $4.35 | -26.13% |
| Sep 2026 | $4.31 | $4.99 | $5.32 | -0.06% |
| Oct 2026 | $4.39 | $4.40 | $5.07 | -11.75% |
| Nov 2026 | $3.90 | $4.25 | $4.51 | -14.86% |
| Dec 2026 | $3.62 | $4.22 | $4.69 | -15.43% |
In 2026, Immuneering Corp (IMRX) is projected to range from $3.12 to $5.32.
Immuneering Corp 2026 monthly forecast
In Aug 2026, Immuneering Corp is projected to average $3.69, with a low of $3.12 and high of $4.35.
In Sep 2026, Immuneering Corp is projected to average $4.99, with a low of $4.31 and high of $5.32.
In Oct 2026, Immuneering Corp is projected to average $4.40, with a low of $4.39 and high of $5.07.
In Nov 2026, Immuneering Corp is projected to average $4.25, with a low of $3.90 and high of $4.51.
In Dec 2026, Immuneering Corp is projected to average $4.22, with a low of $3.62 and high of $4.69.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.